ingly high coronary restenosis rate (8 [80%] of 10 successful attempts), but when calcium antagonists were continued for an average of 6 ± 4 months after angloplasty, the restenosis rate was low (3 [21%] of 14 successful attempts).
After a mean (± SD) follow-up period of 33 ± 13 months, I patient had died and the 20 others (95%) were symptom-free; among these 20, 15 patients (75%) had been taking no antianginal drugs for more than 1 year, 2 still received calcium channel antagonists and 3 had had coronary bypass surgery. Repeat coronary arteriography performed 14 ± 7 months after angioplasty in the 17 patients without angioplasty-related infarction or surgery showed 50% or less coronary stenosis in 13 patients. Thus, coronary angioplasty appears to be an effective alternative therapy for patients with variant angina and organic coronary stenosis. (J Am Coil Cardiol 1985; 5:1046-54) or a normal or exaggerated vasomotion in response to various stimuli remains to be established (3) .
The coronary anatomy of patients with variant angina is quite variable , ranging from angiographically normal coronary arteries (4) to severe multivessel disease (3, (5) (6) (7) . However, the majority of patients with variant angina have some degree of organic stenosis in the coronary artery susceptible to spasm, and when present, the organic stenosis is the site in that vessel where the spasm occurs in about 90% of cases (8) .
The respective roles of spasm and fixed obstruction in occluding a coronary artery may vary from patient to patient (9) . According to MacAlpin (10) , significant coronary obstruction , even complete occlusion, can be dynamically produced by physiologic degrees of vasoconstriction when superimposed on even "insignificant" atheromatous stenosis. Although an inappropriate active constriction appears more likely than a physiologic one (II), for the same stimulus resulting in a similar muscle contraction, the higher the degree of coronary stenosis, the higher the degree of luminal reduction and impairment of flow. Under these conditions, eliminating the organic stenosis would theoretically prevent vasoconstrictive occlusion of the artery and would relieve symptoms in patients with variant angina. Therefore, we considered percutaneous transluminal coronary angioplasty as an alternative treatment for patients with variant angina and significant coronary artery stenosis. In this report, we describe immediate and long-term results of coronary angioplasty and discuss the implications of our findings.
Methods
Patients. Between February 1980 and January 1983, a total of 268 patients underwent coronary angioplasty at the Montreal Heart Institute. Twenty-one of these patients were considered to have variant angina. This was defined as spontaneous angina at rest with transient ST segment elevation of at least 0.2 mY, relieved by nitroglycerin in less than 5 minutes and without subsequent evidence of myocardial necrosis. It was also diagnosed when these events were provoked by ergonovine administration.
The 21 patients were aged 36 to 69 years (mean ± SO 49 ± 10), all but 4 were men, all had rest angina for less than 8 months (mean ± SO 2 ± 2) and all but 4 had effort angina for I to 48 months (mean ± SO 6 ± II).
In most of the 21 patients, the diagnosis of variant angina was made after referral and during hospitalization before coronary angioplasty. In 7 of the 21 , the diagnosis was made only after angioplasty from the demonstration of spontaneous or provoked episodes of variant angina within 4 months after the procedure.
Patient management. Efforts were made to record a 12 lead electrocardiogram during spontaneous episodes of angina at rest. Candidates for coronary angioplasty underwent a graded treadmill exercise test with monitoring of IS electrocardiographic leads with or without thallium-201 studies, with the exception of patients thought to have unstable angina. Patients were exercised during midmorning using a Bruce protocol modified by adding a 3 minute warmup stage at 1.7 mph at a 5% grade (12, 13) . In patients with suspected or documented variant angina, an ergonovine test was performed in the coronary care unit (using a protocol described in detail elsewhere [14] ) if the patient had recently undergone coronary arteriography, or occasionally during coronary arteriography. Administration of ergonovine was stopped if the test was still negative at a dose of 0.4 mg. Before the angioplasty procedure, all patients were premedicated with platelet function inhibitors (either sulfinpyrazone, 200 mg orally four times daily, or dipyridamole. 75 mg orally three times daily, plus aspirin, 650 mg orally once daily) and diltiazem (90 or 120 mg orally three times daily) on the day before and the morning of coronary angioplasty.
Angioplasty technique.
At the beginning of the procedure, low molecular dextran, 500 ml, was infused intravenously at a rate of ISO ml/h, a bolus of 10,000 IU of heparin was administered intravenously and a nitroglycerin infusion was started at a rate of 10 to 30 JLg/min. Intracoronary nitroglycerin was administered as required during the procedure. Selective right and left coronary arteriography was performed immediately before and after coronary angioplasty by the percutaneous femoral approach using preshaped polyethylene catheters (15). Coronary arteries were filmed in multiple views, including craniocaudal and caudocranial sagittal-angulated views (16) .
Coronary angioplasty was performed according to the technique initially described by Gruentzig and Mayer and their coworkers (17, 18) . AU. S. Catheter and Instrument Corporation inflation device was used for balloon inflation; the inflation medium was contrast agent warmed and diluted to 30% of the usual concentration. The number of balloon inflations varied depending on the appearance of the lesion as filmed during control angiography in at least three views and on the residual gradient across the stenosis. Angioplasty was termed successful if there was 20% or greater improvement in the luminal diameter of at least one coronary stenosis. Reduction of transstenotic pressure gradient was used as a guide, but not as a sole criterion of success. For 24 hours after coronary angioplasty , all patients underwent continuous electrocardiographic monitoring.
Follow-up.
All patients were asked to report to the hospital for clinical evaluation and a graded treadmill exercise test with 15 electrocardiographic leads at I, 3 and 6 months after coronary angioplasty, including thallium-201 scans at the I and 6 month exercise tests (13, 19) . In all patients, coronary arteriography was performed 6 to 8 months after angioplasty or sooner if restenosis was suspected (20) . Several patients had a second postangioplasty angiogram after 12 to 25 months. All patients received platelet function inhibitors for 6 months after angioplasty (21) . Medical treatment of variant angina after angioplasty varied from patient to patient and was influenced by the results of treatment in earlier cases. Calcium channel antagonists were not administered after angioplasty in the first few patients or when variant angina had not been diagnosed, but subsequent patients with known variant angina received them (usually diltiazem, 120 mg three times daily). In most patients with coronary restenosis, calcium channel antagonists were restarted when angina recurred. Calcium channel antagonist drugs were discontinued at least 24 hours before the ergonovine tests and whenever possible before the exercise tests.
All angiographic films were interpreted independently by an experienced cardiovascular radiologist. Coronary artery stenoses were defined according to the criteria of the Coronary Artery Surgery Study (22) . The estimated percent of obstruction was derived from the angiographic view showing the greatest reduction in diameter for the vessel in ques- Patients Before Coronary Angioplasty ginal attack occurred during hospitalization and the diagnosis was made after ergonovine administration. In the 10 tion. All measurements were made after the administration of nitroglycerin, and all comparisons between pre-and postangioplasty films were made using the same view. Coronary restenosis was defined as a 20% or greater decrease in luminal diameter of the stenosis compared with the coronary angiogram immediately after angioplasty, resulting in a coronary stenosis of more than 50% at repeat angiography.
Results Tables I to 6 summarize the clinical and angiographic data before and after coronary angioplasty for the 21 patients in this study. For clarity, the patients were classified into three groups according to the results of angioplasty: primary failure, restenosis or late success.
Findings before angioplasty (Tables 1 and 2 ). Variant angina was documented before angioplasty in two-thirds (14 of 21) of the patients; in 9 of these 14, transient ST elevation was present on an electrocardiogram recorded during spontaneous episodes of angina; in the other 5 patients, no an- exercise test that in six patients induced ST elevation in the same electrocardiographic leads in which ST elevation occurred durin g spo ntaneous or provoked anginal atta cks , and in four patients induced ST depression . In the rema ining four patients the test produced no ST abnormality; in two of the four, a reversible perfu sion defect was demonstrated on the thallium exercise scan and in the other two , the exercise test was stopped becau se of fatigue at 3 minut es or less. All patients had single vessel coronary disease with no addi tional narrowings of greate r than 50 % in the other co ronary arteries. except for Pat ient 6, who had a 65% stenosis of the posterior descending artery . The coronary stenosis was graded between 60 and 95% and was located in the left anterio r descending artery in all but 3 patients (in the pro ximal third in 15 patients) . ST elevatio n before or after coronary angioplasty was located in the anterior electrocardio- Neg "Elective coronary artery bypass surgery; temergency coronary artery bypass surgery; :l:myocardial infarction. Neg = negative. (Tables 3 to 6 ).
Angioplasty was successful in all but two patients (Table 5) .
Failures. In Patient I, the lesion could not be crossed, variant angina continued despite optimal medical therapy and she underwent coronary bypass surgery associated with plexectomy 12 isodes of variant angina occurred in the early postoperative period. In Patient 2, the results of angioplasty were poor and there was an 80% residual stenosis. Effort angina persisted despite medical therapy and a second angioplasty was attempted I month later. It resulted in a coronary dissection with complete coronary occlusion complicated by a myocardial infarction that was not prevented by emergency coronary bypass surgery associated with plexectomy.
Primary 5ucce55. Coronary angioplasty was successful in 19 (90%) of the 21 patients (Fig. IA and B , Tables 5  and 6 ). The primary success rate in our first 268 patients who underwent angioplasty during the same period was 68%. None of the first angioplasty attempts in the 21 patients was complicated by coronary spasm during the procedure.
Soon after successful angioplasty in the 19 patients, all but 4 patients were symptom-free (Table 3) . Patient 5 had recurrence of rest and effort angina I month after angioplasty. Coronary angiography showed a 35% residual stenosis with a spontaneous superimposed spasm resulting in a 95% narrowing suppressed by nitroglycerin and reinduced A. Before the first percutaneous transluminal coronary angioplasty, the arteriogram reveals an 85% mid-right coronary artery stenosis. B, Immediately after angioplasty, this stenosis is reduced to 35%. C, Angina recurred approximately 4 months after angioplasty; the right coronary artery stenosis at the site of angioplasty isjudged to be 70% (other angiographic views showed a tighter stenosis). D, A second coronary angioplasty was performed, reducing the stenosis to 50% (also better shown in otherviews). E, Sixmonths later, theangiogram shows a 35% stenosis at the site of angioplasty. F, Onthe angiogram 18 months after thesecond coronary angioplasty, the stenosis is only 20%.
by ergonovine administration; with calcium channel antagonists, the ergonovine test became negative, but angina persisted. Patient 8 did not show improvement after angioplasty. Patient 12 had episodes of variant angina immediately and 3 days after angioplasty but became symptom-free with calcium channel antagonists. Patient 21 had an inferior myocardial infarction 2 weeks after angioplasty. Ergonovine administration induced severe spasm of the right coronary artery but did not modify the 25% residual stenosis at the origin of the left circumflex artery; spontaneous right coronary artery spasm evident on the angiogram immediately before angioplasty had been overlooked. The ergonovine test became negative in four of the five asymptomatic patients who underwent this test before hospital discharge.
Coronary restenoses. Angina persisted or recurred I to 4 months after coronary angioplasty in nine patients (Cases 3 to II, Table 3 ). Seven of these nine patients had an exercise test that induced ST depression in all but one patient. Four patients also had an ergonovine test that induced chest pain and ST segment shifts in all. These nine syrnptomatic patients had coronary restenosis at repeat angiography I to 4 months after angioplasty (Fig. IC) . In two patients (Cases 3 and 5) in whom restenosis was diagnosed at 4 months, a first repeat angiogram was performed. respectively, at 2 months and I month after angioplasty had shown ergonovine-induced coronary spasm at the site of angioplasty without coronary restenosis at that time.
Late success. Coronary angiography 6 months after angioplasty showed no coronary restenosis in Patients 12 to 20, who were symptom-free while taking calcium channel antagonists after coronary angioplasty, or in Patient 21, who had a myocardial infarction while not taking calcium channel antagonists 2 weeks after angioplasty and who later became symptom-free while taking these agents (Table 3) . Patient 15 had recurrent rest and effort angina 4 months after angioplasty while on nifedipinc therapy; an exercise test induced ST elevation at the II th minute, but repeat angiography did not show coronary restenosis. This patient became symptom-free when diltiazem was added to the nifedipine regimen.
Restenosis, angina and calcium channel antagonists. With the exception of Patients 15 and 21, all patients with persistent or recurrent angina after coronary angioplasty had restcnosis at control angiography I to 4 months later and all asymptomatic patients had continued success after angioplasty (Table 3) .
In the II patients taking calcium channel antagonists immediately after successful angioplasty, all but 3 (Cases 9. 10 and 15) no longer experienced variant angina and the restenosis rate was 18% (2 of II patients). In the eight patients not taking calcium channel antagonists immediately after successful angioplasty , the restenosis rate was 86% (seven of eight patient s).
Management of restenosis . With the exception of Patients 4 and 7 in whom variant angina was not diagnosed until after the second coronary angioplasty , patients with restenosis were treated with calcium channel antagonists, usually in addition to a second angioplasty attempt. Repeat angioplasty was attempted in six patients; it was successful in five (Fig . 10, E, F, Table 5 ), but failed in Patient 6 (who underwent angioplasty on a coronary stenosis slightly distal to the site of the initial angioplasty). In this patient, coronary spasm developed during the procedure, completely occluding the left anterior descending artery at the site of the initial angioplasty, and intracoronary nitroglycerin was required for relief of spasm. Six hours later, the patient had an acute anterior infarction that was compli cated by two episodes of ventricular fibrillation and transient heart failure; this patient died suddenly I month later . The autopsy revealed a hemorrhage under a plaque associated with a 95% stenosis of the left anterior descending artery, an anteroseptal infarction and a mural thrombus. Patient 5 developed a new 75% left main coronary artery steno sis not present at angioplasty or at repeat angiography I month after angioplasty and also had a 75% restenosis of the left anterior descending artery ; this patient underwent a double aortocoronary bypass graft procedure the day after repeat angiography, but surgery was complicated by an acute myocardial infarction . Two patients (Cases 8 and 9) were treated with calcium channel antagonists alone .
Of the five patients who had a successful second coronary angioplasty, three were taking calcium channel antagonists and two of them had a late success . The remaining two patient s did not receive calcium channel antagonists because variant angina was not diagnosed before the second angioplasty . In Patient 4, rest angina recurred 6 weeks after the second angioplasty and at repeat angiography a 60% stenosi s with provoked superimposed coronary spasm was shown at the site of angioplasty. The patient had become symptomfree while taking calcium channel antagonists, but subsequent angiography revealed a complete occlusion at the site of angioplasty. In Patient 7, rest angina recurred I week after repeat angioplasty; calcium channel antagonist therapy was started I month after angioplasty and the patient became symptom-free without coronary restenosi s.
Restenosis and calcium channel antagonists (all angioplasty attempts). In the overall 24 successful coronary angioplasty attempts (19 primary succes ses and 5 successful repeat angioplasties), the restenosis rate was 21% (3 of 14) when patients had received calcium channel antagonists soon after angioplasty, and 80% (8 of 10) when calcium channel antagonists were not administered soon after angioplasty (Tables 3 and 5 ). This difference is statistically significant (p < 0 .014, Fisher's exact test) .
Late outcome. The mean (± SO) duration of clinical follow-up was 33 ± 13 months (range 6 to 48) (Tables 3  and 4) . One patient died , but all the others remained symptom-free. Three had coronary bypass surgery and no longer required antianginal therapy. Two were still taking calcium channel antagonists. In each of the remaining 15 patients, calcium channel antagonists have been discontinued for more than 1 year (mean ± SO 25 ± 10 months), and these patients remained symptom-free. Calcium channel antagonists were stopped 6 ± 4 months after coronary angioplasty in patients with continued success and 12 ± 3 months after repeat angioplasty in patients who had restenosis.
Repeat angiography was available at 14 ± 7 months (range 6 to 25) in all 17 patients who had neither myocardial infarction associated with angioplasty nor surgery (Tables  5 and 6 ). One had a complete coronary occlusion at the site of angioplasty and three still had a significant coronary stenosis of greater than 50% , with spontaneous superimposed spasm in one patient (Case II). Twelve patients underwent an ergonovine test which was usually performed during the last repeat angiographic study. The test was negative in eight patients but induced a 70% spasm in Patient 3; it was positive in four patients at a relatively high dose level of ergonovine (0.2 mg or more).
Discussion
Organic coronary stenosis in variant angina. Previous reports (23 ,24) showed that in patients with variant angina the extent and severity of organic coronary stenoses were the strongest predictors of survival and survival without myocardial infarction. Patients with variant angina should undergo coronary angiography since the clinical or electrocardiographic manifestations do not distinguish patients with angiographically normal coronary arteries from those with severe proximal obstructive lesions . In fact, the therapeutic choice may depend, to a great extent, on the presence or absence of organic atherosclerotic lesions associated with coronary spasm.
Coronary spasm associated with significant atherosclerotic coronary lesions is relatively frequent; among 162 consecutive patients with variant angina undergoing coronary arteriography at our institution, 59% had organic lesions of 70% or more (23) . Until recently, coronary bypass surgery was the only available therapy for immediate revascularization in these patients . However, coronary bypass surgery is associated with a higher operative risk, a higher postoperative myocardial infarction rate and poorer results in these patients than in other subsets of patients with fixed coronary obstructions (6, (25) (26) (27) .
Coronary angioplasty in variant angina. Until recently, coronary spasm was considered a contraindication to coronary angioplasty. Indeed, since coronary spasm occurred in 2% of patients undergoing angioplasty and was associated with myocardial infarction (17) or the need for emergency coronary bypass surgery (28) in some patients, angioplasty on an artery already affected by coronary spasm seemed difficult and risky.
This study confirms our preliminary results (29) using angioplasty for the treatment of variant angina and shows that angioplasty is technically feasible in patients with this condition. Moreover, the primary success rate in these patients was higher than that of the overall population of patients undergoing coronary angioplasty during the same period, This probably occurred because most of our patients fulfilled the ideal criterion for selection for angioplasty, namely, discrete proximal noncalcified stenosis in a single major coronary artery suitable for coronary artery surgery (17) , This pattern is more frequent in patients with variant angina (29) than in the average group of patients undergoing coronary arteriography (30) . Coronary spasm occurred in only two patients during 28 procedures (during repeat angioplasty for both patients) and was complicated by myocardial infarction in one. In the other patient with angioplasty-related myocardial infarction, this complication was due to coronary dissection. Thus, the incidence of complications, particularly those related to coronary spasm, does not appear to be much higher in these patients than that in other patients who undergo coronary angioplasty (31) or in patients with active variant angina (32) .
Role of spasm in restenosis after coronary angioplasty. Coronary spasm demonstrated during the first 4 months after angioplasty may be a different problem. Variant angina was diagnosed after angioplasty in 7 of our 181 patients successfully treated with angioplasty, and Hollman et al. (33) recently described 5 patients representing 5 of their 6 reported cases among 1,000 successful attempts. Interestingly all of our seven patients and three of their five patients had rest angina before angioplasty. Three of their patients had a coronary stenosis of less than 60% before angioplasty (one had an insignificant 37% coronary stenosis 2 weeks after a myocardial infarction). Only I of these 13 patients had an ergonovine test before angioplasty. Coronary spasm did not develop immediately after angioplasty-induced balloon injury, but after a symptom-free interval of several days or weeks. In this setting, it appears difficult to assume that coronary spasm diagnosed after angioplasty is directly related to it. Variant angina occurring before angioplasty, but discovered only after the procedure, appears much more likely.
In two of our nine patients with coronary restenosis and in four of the patients described by Hollman et al. (33) , coronary spasm in hemodynamically insignificant lesions was demonstrated 2 to 7 months before the diagnosis of restenosis. This finding, plus the fact that the rate of restenosis is much higher in patients with variant angina than in patients with a fixed coronary obstruction and seems to be prevented by calcium channel antagonists, supports the hypothesis that persistence of coronary spasm may playa role in the pathogenesis of restenosis in patients with variant angina. The possibility of variant angina should, thus, be considered in patients with rest angina referred for coronary angioplasty and in patients with restenosis after angioplasty because they probably need specific medical management after angioplasty similar to that of patients with variant angina undergoing coronary bypass surgery (34) .
Long-term clinical results. Our long-term clinical results must be interpreted with caution because spontaneous remission is a frequent outcome of variant angina. However, our proportion of patients currently symptom-free without medical treatment for more than I year may be higher than the rate reported in patients who had medical treatment alone (35) . Survival rate and survival rate without myocardial infarction in our series are not different from those of patients with variant angina and single vessel disease who had medical or surgical therapy (23, 24) . In patients with variant angina and multi vessel disease who have been shown to have the worst prognosis (23) and for whom coronary bypass surgery has been advised, we have not yet had any experience of successful revascularization using coronary angioplasty. We also have no experience of coronary angioplasty for mild to moderate « 50 to 60%) coronary stenoses in vessels that exhibit coronary spasm; however, because of the questionable role of these mild lesions, we doubt that variant angina can be better controlled by coronary angioplasty plus calcium channel antagonists than by calcium channel antagonists alone in most patients with these mild fixed stenoses.
Role of calcium channel antagonists after angioplasty. In patients with variant angina and organic coronary stenoses, coronary angioplasty is usually successful, but restenoses, which may be induced by recurrent episodes of coronary spasm. are frequent and seem to be prevented by continuing administration of calcium channel antagonist drugs for several months after angioplasty. Coronary angioplasty can, thus, be proposed as an alternative therapy for these patients. The subset of patients with variant angina and organic coronary stenoses that should benefit the most from this new method of revascularization remains to be determined.
